CClinicalTrials.gg
CompletedNCT05572866Updated Oct 10, 2022

Impact of COVID-19 Pandemic on Hepatopancreatobiliary Surgical Services in Singapore

An observational study in COVID-19 and Surgery, sponsored by Tan Tock Seng Hospital. Completed at 1 site in Singapore. Open to participants aged 18 Years to 120 Years. Per ClinicalTrials.gov, last updated 2022-10-10.

Sponsored by Tan Tock Seng Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,089
Ages
18 Years to 120 Years
Sex
All
01

Study summary

This paper is intended to report our observational study in evaluating the impact of the COVID-19 pandemic on Tan Tock Seng Hospital hepatopancreatobiliary unit's surgical workload from January to June across 2019 to 2022, corresponding to the pre-pandemic baseline to its peak and the gradual normalization of hospital services as Singapore entered the transition phase to COVID-19 resilience.

Read the detailed description

This paper is intended to report our observational study in evaluating the impact of the COVID-19 pandemic on Tan Tock Seng Hospital hepatopancreatobiliary unit's surgical workload from January to June across 2019 to 2022, corresponding to the pre-pandemic baseline to its peak and the gradual normalization of hospital services as Singapore entered the transition phase to COVID-19 resilience.

A comparative audit of the unit's surgical workload for the months of January-June across 2019 to 2022, which corresponded to pre-COVID-19, the height of the pandemic, and a gradual normalization of surgical services. Operations performed by the unit were collected from the surgeons' electronic case logs. These operations were sorted based on the Singapore Ministry of Health's table of surgical procedures, which assigns charge codes to different procedures. The retrospective data across the 4 years were compared and analysed.

No patient contact or identifiers were retrieved, stored or disseminated and thus exempt from ethics board review.

02

Conditions studied

  • COVID-19
  • Surgery

Browse trials for

03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 1,089 is above the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Tan Tock Seng Hospital is the lead sponsor of 103 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 120 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients who underwent gallbladder, hernia, liver or pancreas resection surgeries during the periods of January to June of 2019/2020/2021/2022.

Inclusion criteria

  • all patients who underwent gallbladder, hernia, liver or pancreas resection surgeries during the periods of January to June of 2019/2020/2021/2022.

Exclusion criteria

Exclusion Criteria:

  • anyone who does not fall within the inclusion criteria
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,089 participants (actual)
Patient registry
No

Groups and cohorts

  • 2019

    No intervention will be carried out. The sum total of surgeries carried out during 2019 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

    Other: COVID-19 pandemic

  • 2020

    No intervention will be carried out. The sum total of surgeries carried out during 2020 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

    Other: COVID-19 pandemic

  • 2021

    No intervention will be carried out. The sum total of surgeries carried out during 2021 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

    Other: COVID-19 pandemic

  • 2022

    No intervention will be carried out. The sum total of surgeries carried out during 2022 will be audited to see how the COVID-19 pandemic has impacted the surgical volume.

    Other: COVID-19 pandemic

Interventions

  • OtherCOVID-19 pandemic

    To retrospectively review the surgical volume across 2019-2022 to see the impact of the COVID-19 pandemic.

06

What researchers measure

Primary outcomes

  1. Number of surgeries done under general anaesthesia by the hepatopancreatobiliary unit

    Operations performed by the unit will be collected from the surgeons' electronic case logs. These operations will be sorted based on the Singapore Ministry of Health's table of surgical procedures, which assigns charge codes to different procedures. The retrospective data across the 4 years will be compared and analysed.

    Time frame: 2019-2022

07

Study locations

1 site
  • Tan Tock Seng Hospital
    Singapore, 308433, Singapore
08

References and documents

Individual participant data

Plan to share: No — There is no plan to make IPD available.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05572866
Lead sponsor
Tan Tock Seng Hospital
Responsible party
Sponsor
First posted
Oct 10, 2022
Start date
Jan 1, 2019
Primary completion
Jun 30, 2022
Completion
Jun 30, 2022
Last update
Oct 10, 2022

Study contacts

Vishalkumar G Shelat, MMed, FRCS
study director · Tan Tock Seng Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion